New Research Poster Presentation 3.42
Time to Onset and Resolution of Adverse Events and Changes in Blood Pressure and Pulse Following Atomoxetine Treatment in Adult Patients with ADHD
Thursday, October 24, 2013
Himanshu P. Upadhyaya, MBBS, MS, Lilly Research Laboratories, Eli Lilly and Company, Bellaire, TX
Yoko Tanaka, PhD, Lilly Research Laboratories, Indianapolis, IN
Sarah Lipsius, MS, inVentiv Health, Ann Arbor, MI
Angelo Camporeale, MD, Lilly Research Laboratories, Indianapolis, IN
Jeannine Lane, PhD, inVentiv Health, Ann Arbor, MI
Rodrigo Escobar, MD, Psychiatry and Pain Disorders, Eli Lilly and Company, Indianapolis, IN
Paula T. Trzepacz, MD, Eli Lilly and Company, Indianapolis, IN
Albert John Allen, MD, PhD, Eli Lilly and Company, Indianapolis, IN
